Skip to main content
. 2021 Aug 9;22(16):8547. doi: 10.3390/ijms22168547

Figure 3.

Figure 3

AVR-48 decreases inflammation and vascular leak. (A) Total inflammatory cells in the BAL fluid in the BPD group is significantly decreased after AVR-48 treatment. (B) Total protein in the BAL fluid in the BPD group is significantly decreased after AVR-48 treatment. * p < 0.05; ** p < 0.01; *** p < 0.001, n = 3–8; RA: room air; BAL: bronchoalveolar lavage; BPD: bronchopulmonary dysplasia.